248 related articles for article (PubMed ID: 33886458)
1. COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease.
Kondo Y; Kaneko Y; Takei H; Tamai H; Kabata H; Suhara T; Yamamoto R; Nagata H; Ishii M; Sasaki J; Hasegawa N; Fukunaga K; Takeuchi T;
Clin Exp Rheumatol; 2021; 39(3):631-638. PubMed ID: 33886458
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients.
Qian J; Li R; Chen Z; Cao Z; Lu L; Fu Q
Front Immunol; 2023; 14():1151695. PubMed ID: 37006269
[TBL] [Abstract][Full Text] [Related]
3. MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C).
David P; Sinha S; Iqbal K; De Marco G; Taheri S; McLaren E; Maisuria S; Arumugakani G; Ash Z; Buckley C; Coles L; Hettiarachchi C; Payne E; Savic S; Smithson G; Slade M; Shah R; Marzo-Ortega H; Keen M; Lawson C; Mclorinan J; Nizam S; Reddy H; Sharif O; Sultan S; Tran G; Wood M; Wood S; Ghosh P; McGonagle D
EBioMedicine; 2024 Jun; 104():105136. PubMed ID: 38723554
[TBL] [Abstract][Full Text] [Related]
4. Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.
Triggianese P; Vitale A; Lopalco G; Mayrink Giardini HA; Ciccia F; Al-Maghlouth I; Ruscitti P; Sfikakis PP; Iannone F; de Brito Antonelli IP; Patrone M; Asfina KN; Di Cola I; Laskari K; Gaggiano C; Tufan A; Sfriso P; Dagna L; Giacomelli R; Hinojosa-Azaola A; Ragab G; Fotis L; Direskeneli H; Spedicato V; Dagostin MA; Iacono D; Ali HH; Cipriani P; Sota J; Kardas RC; Bindoli S; Campochiaro C; Navarini L; Gentileschi S; Martín-Nares E; Torres-Ruiz J; Saad MA; Kourtesi K; Alibaz-Oner F; Sevik G; Iagnocco A; Makowska J; Govoni M; Monti S; Maggio MC; La Torre F; Del Giudice E; Hernández-Rodríguez J; Bartoloni E; Emmi G; Chimenti MS; Maier A; Simonini G; Conti G; Olivieri AN; Tarsia M; De Paulis A; Lo Gullo A; Więsik-Szewczyk E; Viapiana O; Ogunjimi B; Tharwat S; Erten S; Nuzzolese R; Karamanakos A; Frassi M; Conforti A; Caggiano V; Marino A; Sebastiani GD; Gidaro A; Tombetti E; Carubbi F; Rubegni G; Cartocci A; Balistreri A; Fabiani C; Frediani B; Cantarini L
Intern Emerg Med; 2023 Nov; 18(8):2231-2243. PubMed ID: 37828268
[TBL] [Abstract][Full Text] [Related]
5. A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient.
Jeon YH; Lim DH; Choi SW; Choi SJ
Rheumatol Int; 2022 Apr; 42(4):743-748. PubMed ID: 34797392
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
[TBL] [Abstract][Full Text] [Related]
7. [Fever of unknown origin caused by the adult form of Still's disease].
van Guldener C; Nurmohamed SA; van der Horst-Bruinsma IE
Ned Tijdschr Geneeskd; 2000 Jul; 144(29):1410-3. PubMed ID: 10923151
[TBL] [Abstract][Full Text] [Related]
8. Recent advances and evolving concepts in Still's disease.
Ruscitti P; Cantarini L; Nigrovic PA; McGonagle D; Giacomelli R
Nat Rev Rheumatol; 2024 Feb; 20(2):116-132. PubMed ID: 38212542
[TBL] [Abstract][Full Text] [Related]
9. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S
Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894
[TBL] [Abstract][Full Text] [Related]
10. Antimelanoma Differentiation-Associated Gene 5 Antibody-Positive Interstitial Lung Disease After Vaccination With COVID-19 mRNA Vaccines.
Kitajima T; Funauchi A; Nakajima T; Marumo S; Imura Y; Fukui M
J Rheumatol; 2022 Oct; 49(10):1158-1162. PubMed ID: 35705246
[TBL] [Abstract][Full Text] [Related]
11. Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications.
Ruscitti P; Di Cola I; Di Muzio C; Italiano N; Ursini F; Giacomelli R; Cipriani P
Autoimmun Rev; 2022 Jul; 21(7):103114. PubMed ID: 35595050
[TBL] [Abstract][Full Text] [Related]
12. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
[No Abstract] [Full Text] [Related]
13. Clinical significance of HScore and MS score comparison in the prognostic evaluation of anti-MDA5-positive patients with dermatomyositis and interstitial lung disease.
Zhao S; Ma X; Zhang X; Jin Z; Hu W; Hua B; Wang H; Feng X; Sun L; Chen Z
Mod Rheumatol; 2022 Feb; 32(2):373-379. PubMed ID: 34894256
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
15. The coexistence of Sweet's syndrome and Still's disease--is it merely a coincidence?
Elinav H; Maly A; Ilan Y; Rubinow A; Naparstek Y; Amital H
J Am Acad Dermatol; 2004 May; 50(5 Suppl):S90-2. PubMed ID: 15097938
[TBL] [Abstract][Full Text] [Related]
16. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
Sakamoto S; Okamoto M; Kaieda S; Fujimoto K; Nagata S; Tominaga M; Nakamura M; Zaizen Y; Nouno T; Koga T; Kawayama T; Kuwana M; Ida H; Hoshino T
Respir Investig; 2018 Nov; 56(6):464-472. PubMed ID: 30150008
[TBL] [Abstract][Full Text] [Related]
17. Fever of unknown origin and leukemoid reaction as initial presentation of adult-onset Still's disease.
Pardo-Cabello AJ; Manzano-Gamero V; Javier-Martínez R
Acta Reumatol Port; 2014; 39(1):98-9. PubMed ID: 24811471
[TBL] [Abstract][Full Text] [Related]
18. Response to: 'Comparison of MS score and HScore for the diagnosis of adult-onset Still's disease associated macrophage activation syndrome' by Zhang
Minoia F; Ravelli A
Ann Rheum Dis; 2022 Jun; 81(6):e100. PubMed ID: 32611601
[No Abstract] [Full Text] [Related]
19. Adult-onset Still's disease with disseminated intravascular coagulation and hemophagocytic syndrome: a case report.
Mimura T; Shimodaira M; Kibata M; Tsukadaira A; Shirahata K
BMC Res Notes; 2014 Dec; 7():940. PubMed ID: 25532568
[TBL] [Abstract][Full Text] [Related]
20. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
